Sugemalimab (Anti-B7-H1 / PD-L1 / CD274)Sugemalimab (Anti-B7-H1 / PD-L1 / CD274)
Move your mouse over image or click to enlarge

Sugemalimab (Anti-B7-H1 / PD-L1 / CD274)

Sugemalimab (Anti-B7-H1 / PD-L1 / CD274) is a fully human anti-programmed death ligand 1 (PD-L1) immunoglobulin G4 (IgG4) monoclonal antibody (mAb). Sugemalimab shows anticancer activities and can be used for non-small-cell lung cancer research. MW: 143.36 kD.
Cat# Size Price Qty Buy
A2783-1mg*25 1mg*25
£6,363.00
A2783-1mg*5 1mg*5
£2,121.00
A2783-1mg 1mg
£712.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2783

Related Documents